SSMXY Sysmex Corporation
Sysmex Corporation (SSMXY) is expected to report earnings on November 6, 2026, before the market open. The consensus earnings estimate is $0.11 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +11.4% since its last earnings release on August 7, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Sysmex Corporation
Sysmex Corporation is engaged in the development, manufacture, import, export and sale of clinical laboratory instruments, reagents and software used in -vitro diagnostics. It also provides clinical laboratory testing of blood, urine and other specimens. The company's product includes instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis and point-of-care testing. Its operating segment consists of Japan, Americas, EMEA, China and Asia Pacific. Sysmex Corporation is headquartered in Kobe, Japan.
Sector
Healthcare
Industry
Medical Instruments/Supply